Generated Narrative: RegulatedAuthorization FOPH-20416 CH - EPL Reimbursement SL FOPHDossierNumber: FOPH Dossier Number/20416 status: Reimbursed statusDate: 2023-01-01 expiryDate: 2025-03-31 listingStatus: Listed listingPeriod: 2023-01-01 --> 2024-12-31 firstListingDate: 2017-09-01 costShare: 10 gamme: Parenteral Depot CH - EPL Product Price value: CHF4,407.68 (CHF) type: Ex-factory price changeType: Normal price mutation changeDate: 2023-01-01 CH - EPL Product Price value: CHF4,768.50 (CHF) type: Retail price changeType: VAT-change changeDate: 2024-01-01 subject: PackagedProductDefinition: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-PCID#CH-7601001001138-6623101-001; containedItemQuantity = 1 Vial; description = KEYTRUDA Inf Konz 100 mg/4ml Durchstf type: Reimbursement SL Indications - Extension Reference * ClinicalUseDefinition: type = indication holder: Organization MSD Merck Sharp & Dohme AG Generated Narrative: Organization #holder-MSD-Merck-Sharp-Dohme-AG Profile: CH EPL Organization identifier: LOC Identifier/100080484, GLN Identifier/7601001001138 name: MSD Merck Sharp & Dohme AG